Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+5.96M
-
Total reported value, excl. options
-
$387M
-
Value change
-
+$44.1M
-
Put/Call ratio
-
0.33
-
Number of buys
-
84
-
Number of sells
-
-43
-
Price
-
$7.26
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2016
154 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2016.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 106M outstanding shares and own 50.38% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (13.9M shares), INGALLS & SNYDER LLC (8.16M shares), VANGUARD GROUP INC (3.39M shares), BlackRock Fund Advisors (3.3M shares), BlackRock Institutional Trust Company, N.A. (2.15M shares), MORGAN STANLEY (1.65M shares), RENAISSANCE TECHNOLOGIES LLC (1.51M shares), INVESTOR AB (1.38M shares), Invesco Ltd. (1.34M shares), and STATE STREET CORP (1.26M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.